Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China
· Delayed Price · Currency is CNY 29.43
-0.09 (-0.30%)
At close: Mar 9, 2026
SHE:301263 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 12,464 | 6,348 | 6,948 | 7,683 | - | - | Upgrade
|
| Market Cap Growth | 78.47% | -8.63% | -9.56% | - | - | - | Upgrade
|
| Enterprise Value | 12,307 | 6,066 | 6,271 | 6,685 | - | - | Upgrade
|
| Last Close Price | 29.43 | 14.88 | 15.88 | 17.24 | - | - | Upgrade
|
| PE Ratio | 535.17 | 58.66 | 43.37 | 44.00 | - | - | Upgrade
|
| Forward PE | - | 25.85 | 22.52 | 28.32 | - | - | Upgrade
|
| PS Ratio | 18.48 | 8.81 | 9.13 | 9.81 | - | - | Upgrade
|
| PB Ratio | 6.89 | 3.50 | 3.80 | 4.14 | - | - | Upgrade
|
| P/TBV Ratio | 9.38 | 4.56 | 4.86 | 4.36 | - | - | Upgrade
|
| P/FCF Ratio | - | 305.50 | - | 130.35 | - | - | Upgrade
|
| P/OCF Ratio | 322.19 | 71.07 | 74.29 | 51.63 | - | - | Upgrade
|
| EV/Sales Ratio | 18.25 | 8.41 | 8.24 | 8.53 | - | - | Upgrade
|
| EV/EBITDA Ratio | 193.29 | 37.34 | 28.37 | 29.48 | - | - | Upgrade
|
| EV/EBIT Ratio | - | 55.12 | 34.14 | 34.32 | - | - | Upgrade
|
| EV/FCF Ratio | -194.04 | 291.91 | - | 113.43 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.22 | 0.13 | 0.10 | 0.01 | 0.15 | 0.21 | Upgrade
|
| Debt / EBITDA Ratio | 6.12 | 1.48 | 0.79 | 0.10 | 0.70 | 0.59 | Upgrade
|
| Debt / FCF Ratio | - | 11.68 | - | 0.39 | 1.45 | 3.90 | Upgrade
|
| Net Debt / Equity Ratio | -0.13 | -0.23 | -0.29 | -0.55 | -0.04 | 0.06 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.73 | -2.59 | -2.40 | -4.52 | -0.18 | 0.15 | Upgrade
|
| Net Debt / FCF Ratio | 3.65 | -20.28 | 4.99 | -17.38 | -0.38 | 1.02 | Upgrade
|
| Asset Turnover | 0.29 | 0.32 | 0.36 | 0.53 | 0.74 | 0.94 | Upgrade
|
| Inventory Turnover | 2.65 | 3.33 | 3.64 | 4.18 | 3.70 | 3.33 | Upgrade
|
| Quick Ratio | 2.04 | 2.68 | 4.21 | 9.15 | 2.23 | 1.64 | Upgrade
|
| Current Ratio | 2.38 | 3.05 | 4.69 | 9.81 | 2.66 | 2.20 | Upgrade
|
| Return on Equity (ROE) | 0.77% | 5.32% | 8.33% | 13.62% | 18.47% | 28.25% | Upgrade
|
| Return on Assets (ROA) | -0.04% | 3.03% | 5.38% | 8.17% | 8.98% | 15.85% | Upgrade
|
| Return on Invested Capital (ROIC) | -0.11% | 7.51% | 13.78% | 21.71% | 17.07% | 26.73% | Upgrade
|
| Return on Capital Employed (ROCE) | -0.10% | 5.70% | 9.30% | 10.30% | 17.30% | 31.00% | Upgrade
|
| Earnings Yield | 0.19% | 1.70% | 2.31% | 2.27% | - | - | Upgrade
|
| FCF Yield | -0.51% | 0.33% | -1.53% | 0.77% | - | - | Upgrade
|
| Dividend Yield | 0.68% | 1.34% | 1.89% | 2.26% | - | - | Upgrade
|
| Payout Ratio | 405.57% | 124.86% | 104.11% | 49.14% | 3.56% | 42.37% | Upgrade
|
| Buyback Yield / Dilution | -1.69% | 1.27% | -6.23% | -24.87% | -6.49% | -5.67% | Upgrade
|
| Total Shareholder Return | -1.01% | 2.61% | -4.34% | -22.62% | -6.49% | -5.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.